BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26741957)

  • 1. Antipsychotic Therapy-Induced New Onset Diabetic Ketoacidosis.
    Agrawal Y; Lingala K; Tokala H; Kalavakunta JK
    Am J Ther; 2016; 23(6):e1944-e1945. PubMed ID: 26741957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-lnduced hyperglycemic nonketonic coma.
    Roefaro J; Mukherjee SM
    Ann Pharmacother; 2001 Mar; 35(3):300-2. PubMed ID: 11261526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature.
    Ahuja N; Palanichamy N; Mackin P; Lloyd A
    J Psychopharmacol; 2010 Jan; 24(1):125-30. PubMed ID: 18801826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine.
    Howes OD; Rifkin L
    J Psychopharmacol; 2004 Sep; 18(3):435-7. PubMed ID: 15358991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-induced diabetic ketoacidosis in a Chinese man.
    Wong JO; Fu JC; Hung GB
    Hong Kong Med J; 2007 Feb; 13(1):73-4. PubMed ID: 17277396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New onset diabetes with ketoacidosis attributed to quetiapine.
    Marlowe KF; Howard D; Chung A
    South Med J; 2007 Aug; 100(8):829-31. PubMed ID: 17713311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycemic, hyperosmolar nonketotic coma (HHNC).
    Kitabchi AE; Matteri R; Murphy MB
    Diabetes Care; 1982; 5 Suppl 1():78-87. PubMed ID: 6821307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low doses of insulin--comparison between hyperosmolar nonketotic coma and diabetic ketoacidosis (author's transl)].
    Pelosi RM; Reis LC
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):249-58. PubMed ID: 103144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis associated with aripiprazole.
    Makhzoumi ZH; McLean LP; Lee JH; Ibe AI
    Pharmacotherapy; 2008 Sep; 28(9):1198-202. PubMed ID: 18752391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate-Intensity Insulin Therapy Is Associated With Reduced Length of Stay in Critically Ill Patients With Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State.
    Firestone RL; Parker PL; Pandya KA; Wilson MD; Duby JJ
    Crit Care Med; 2019 May; 47(5):700-705. PubMed ID: 30855284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole.
    Campanella LM; Lartey R; Shih R
    Ann Emerg Med; 2009 Feb; 53(2):264-6. PubMed ID: 18468728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy.
    Bastin M; Mosbah H; Carlier A; Boudifa A; Villemain A; Hartemann A; Andreelli F
    Diabetes Metab; 2020 Oct; 46(5):406-407. PubMed ID: 31034979
    [No Abstract]   [Full Text] [Related]  

  • 13. An atypical hyperosmolar hyperglycemic state and diabetic ketoacidosis induced by sodium-glucose cotransporter-2 inhibitors: A case report.
    Wang CT; Chang CW; Lu YC; Lam HC; Ku SJ; Tseng KB; Kao YH
    J Formos Med Assoc; 2020 Aug; 119(8):1325-1328. PubMed ID: 31813656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
    Ramaswamy K; Kozma CM; Nasrallah H
    Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature.
    Varma MK; Connolly K; Fulton B
    J Intensive Care Med; 2007; 22(1):52-5. PubMed ID: 17259569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics and diabetes mellitus: an association.
    Liberty IF; Todder D; Umansky R; Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):276-9. PubMed ID: 15151366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.
    Koller EA; Weber J; Doraiswamy PM; Schneider BS
    J Clin Psychiatry; 2004 Jun; 65(6):857-63. PubMed ID: 15291665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis and hyperosmolar nonketotic state: gaining control over extreme hyperglycemic complications.
    Gonzalez-Campoy JM; Robertson RP
    Postgrad Med; 1996 Jun; 99(6):143-52. PubMed ID: 8668627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating effects of olanzapine on the development of diabetic ketoacidosis.
    Tsuchiyama N; Ando H; Ota T; Sakurai M; Takamura T
    Diabet Med; 2004 Mar; 21(3):300-1. PubMed ID: 15008848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.